{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:44:49Z","timestamp":1780497889761,"version":"3.54.1"},"reference-count":78,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>The European Commission\u2019s 2019 report regarding the state of health profiles highlighted the fact that Romania is among the countries with the lowest life expectancy in the European Union. Therefore, the objectives of the present study were to assess the current prescription habits of general physicians in Romania related to medicines taken by the elderly population for chronic conditions in both urban and rural setting and to discuss\/compare these practices with the current international recommendations for the elderly (American\u2014Beers 2019 criteria and European\u2014STOPP\/START v.2, 2015 criteria). A total of 2790 electronic prescriptions for chronic pathologies collected from 18 community pharmacies in the western part of Romania (urban and rural zones) were included. All medicines had been prescribed by general physicians. We identified the following situations of medicine overuse: 15% of the analyzed prescriptions involved the use of nonsteroidal anti-inflammatory drugs (NSAIDs) for &gt;2 weeks, 12% involved the use of a proton-pump inhibitor (PPI) for &gt;8 weeks, theophylline was the bronchodilator used as a monotherapy in 3.17% of chronic obstructive pulmonary disease cases, and zopiclone was the hypnotic drug of choice for 2.31% of cases. Regarding the misuse of medicines, 2.33% of analyzed prescriptions contained an angiotensin-converting enzyme (ACE) inhibitor and an angiotensin II receptor blocker (ARB) for patients with renal failure in addition to vitamin K antagonists (AVKs) and NSAIDs in 0.43% of cases. Prescriptions for COX2 NSAIDs for periods longer than 2 weeks for patients with cardiovascular disorders accounted for 1.33% of prescriptions, and trihexyphenidyl was used as a monotherapy for patients with Parkinson\u2019s disease in 0.18% of cases. From the included medical prescriptions, 32.40% (the major percent of 2383 prescriptions) had two potentially inappropriate medications (PIMs). Rural zones were found to be risk factor for PIMs. Decreasing the chronic prescription of NSAIDs and PPIs, discontinuing the use of hypnotic drugs, and avoiding potentially harmful drug\u2013drug associations will have long term beneficial effects for Romanian elderly patients.<\/jats:p>","DOI":"10.3390\/ijerph18137043","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T12:03:27Z","timestamp":1625141007000},"page":"7043","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prescription Habits Related to Chronic Pathologies of Elderly People in Primary Care in the Western Part of Romania: Current Practices, International Recommendations, and Future Perspectives Regarding the Overuse and Misuse of Medicines"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3194-2012","authenticated-orcid":false,"given":"Valentina","family":"Buda","sequence":"first","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"},{"name":"Research Centre for Pharmaco-Toxicological Evaluation, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Prelipcean","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cristescu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandru","family":"Roja","sequence":"additional","affiliation":[{"name":"Faculty of Economics and Business Administration, West University of Timisoara, Vasile Parvan Boulevard, No.4, 300223 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-987X","authenticated-orcid":false,"given":"Olivia","family":"Dalleur","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Research Group, Louvain Drug Research Institute, Universite Catholique de Louvain, E. Mounier Street, No. 81, 1200 Woluwe-Saint-Lambert, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minodora","family":"Andor","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Danciu","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"},{"name":"Research Centre for Pharmaco-Toxicological Evaluation, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3462-1863","authenticated-orcid":false,"given":"Adriana","family":"Ledeti","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"},{"name":"Advanced Instrumental Screening Center, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Adriana","family":"Dehelean","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"},{"name":"Research Centre for Pharmaco-Toxicological Evaluation, \u201cVictor Babes\u201d University of Medicine and Pharmacy, Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavian","family":"Cretu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Eftimie Murgu Square, No. 2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"ref_1","unstructured":"Eurostat 2019 (2021, January 20). State of Health in the EU. Romania. Country Health Profiles 2019. Available online: https:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0009\/419472\/Country-Health-Profile-2019-Romania.pdf."},{"key":"ref_2","unstructured":"Eurostat 2017 (2021, January 20). State of Health in the Eu. Country Health Profiles 2017. Available online: https:\/\/ec.europa.eu\/health\/sites\/health\/files\/state\/docs\/chp_romania_english.pdf."},{"key":"ref_3","unstructured":"European Commission (2021, January 20). Country Report 2016. Available online: https:\/\/ec.europa.eu\/info\/sites\/info\/files\/cr_romania_2016_en.pdf."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101205","DOI":"10.1016\/j.arr.2020.101205","article-title":"Aging in COVID-19: Vulnerability, immunity and intervention","volume":"65","author":"Chen","year":"2021","journal-title":"Ageing Res. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jinf.2020.03.019","article-title":"Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up","volume":"80","author":"Wang","year":"2020","journal-title":"J. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s40520-020-01631-y","article-title":"COVID-19 and the elderly: Insights into pathogenesis and clinical decision-making","volume":"32","author":"Perrotta","year":"2020","journal-title":"Aging Clin. Exp. Res."},{"key":"ref_7","unstructured":"The National Institute of Public Health (Week 05) (2021, February 15). Romania. Available online: https:\/\/www.cnscbt.ro\/index.php\/analiza-cazuri-confirmate-covid19."},{"key":"ref_8","unstructured":"Oertelt-Prigione, S. (2021, February 15). The Impact of Sex Gender in the COVID-19 Pandemic. European Commission\u2013Case Study. Research and Innovation. Research and Innovation. Available online: https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/4f419ffb-a0ca-11ea-9d2d-01aa75ed71a1\/language-en."},{"key":"ref_9","unstructured":"World Health Organization (2021, February 15). Coronavirus Disease Dashboard. Available online: https:\/\/covid19.who.int\/table?tableDay=yesterday."},{"key":"ref_10","unstructured":"Organisation for Economic Co-operation and Development (OECD) (2021, February 15). Influenza Vaccination Rates. Available online: https:\/\/data.oecd.org\/healthcare\/influenza-vaccination-rates.htm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/gerona\/glw140","article-title":"Impact of Potentially Inappropriate Prescribing on Adverse Drug Events, Health Related Quality of Life and Emergency Hospital Attendance in Older People Attending General Practice: A Prospective Cohort Study","volume":"72","author":"Wallace","year":"2017","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/bcp.12995","article-title":"Potentially inappropriate prescribing according to STOPP and START and adverse outcomes in community-dwelling older people: A prospective cohort study","volume":"82","author":"Moriarty","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/bcp.13055","article-title":"Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community-dwelling oldest old","volume":"82","author":"Wauters","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2147\/CIA.S233270","article-title":"Potentially Inappropriate Prescriptions in Ambulatory Elderly Patients Living in Rural Areas of Romania Using STOPP\/START (Version 2) Criteria","volume":"15","author":"Buda","year":"2020","journal-title":"Clin. Interv. Aging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/17512433.2020.1697676","article-title":"STOPP\/START criteria for potentially inappropriate medications\/potential prescribing omissions in older people: Origin and progress","volume":"13","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/ageing\/afu138","article-title":"Best practice guidelines for the management of frailty: A British Geriatrics Society, Age UK and Royal College of General Practitioners report","volume":"43","author":"Turner","year":"2014","journal-title":"Age Ageing"},{"key":"ref_17","unstructured":"National Institute for Health and Care Excellence (2021, January 20). Medicines Optimization: The Safe and Effective Use of Medicines to Enable the Best Possible Outcomes. Available online: https:\/\/www.nice.org.uk\/guidance\/ng5\/chapter\/1-Recommendations#medication-review."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"xiii","DOI":"10.1016\/j.cger.2017.09.007","article-title":"Screening and Prevention in the Modern Era","volume":"34","author":"Cayea","year":"2018","journal-title":"Clin. Geriatr. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/fampra\/cmy022","article-title":"Understanding medical overuse: The case of problematic polypharmacy and the potential of ethnography","volume":"35","author":"Armstrong","year":"2018","journal-title":"Fam. Pract."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(07)61091-5","article-title":"Appropriate prescribing in elderly people: How well can it be measured and optimised?","volume":"370","author":"Spinewine","year":"2007","journal-title":"Lancet"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Primejdie, D.P., Bojita, M.T., and Popa, A. (2016). Potentially inappropriate medications in elderly ambulatory and institutionalized patients: An observational study. BMC Pharmacol. Toxicol., 17.","DOI":"10.1186\/s40360-016-0081-x"},{"key":"ref_22","first-page":"366","article-title":"Potential inappropriate medication use in community-dwelling elderly patients: A qualitative study","volume":"60","author":"Primejdie","year":"2012","journal-title":"Farmacia"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"iv28","DOI":"10.1093\/eurpub\/ckaa127","article-title":"The geriatric workforce in Romania: The need to improve data and management","volume":"30","author":"Ungureanu","year":"2020","journal-title":"Eur. J. Public Health"},{"key":"ref_24","first-page":"909","article-title":"Detection and prevention of frailty in independently living pre-elderly and elderly in Northeastern Romania","volume":"120","author":"Pislaru","year":"2016","journal-title":"Med. Surg. J."},{"key":"ref_25","unstructured":"(2021, February 15). Independent Living Institute. Available online: https:\/\/www.independentliving.org\/toolsforpower\/tools11.html."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"(2019). By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria\u00ae for Potentially Inappropriate Medication Use in Older Adults. J. Am. Geriatr. Soc., 67, 674\u2013694.","DOI":"10.1111\/jgs.15767"},{"key":"ref_27","first-page":"213","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: Version 2","volume":"44","author":"Byrne","year":"2015","journal-title":"Age Ageing"},{"key":"ref_28","unstructured":"Romanian Legislation (2021, January 20). Law 351\/2001. Available online: http:\/\/www.cdep.ro\/pls\/legis\/legis_pck.htp_act_text?idt=28862."},{"key":"ref_29","unstructured":"Stanciu, V. (2021, January 20). Defining the Rural Area in Romania: Legislative Approaches. Econstor. Available online: https:\/\/www.econstor.eu\/bitstream\/10419\/163388\/1\/ICEADR-2016_p293.pdf."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3389\/fpubh.2016.00159","article-title":"Use Your Words Carefully: What Is a Chronic Disease?","volume":"4","author":"Bernell","year":"2016","journal-title":"Front. Public Health"},{"key":"ref_31","unstructured":"(2021, February 15). Casa Judetean de Asigurari de Sanatate Dolj. Available online: http:\/\/www.cnas.ro\/casdj\/post\/type\/local\/ordinul-ms-cnas-privind-aprobarea-formularului-de-prescriptie-medicala-electronica.html."},{"key":"ref_32","unstructured":"Romanian Legislation (2021, February 15). Law 339\/2005. Available online: https:\/\/cmvro.ro\/files\/download\/legislatie\/stupefiante-psihotrope\/Legea_339_2005_stupefiante_psihotrope-consolidata.pdf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4140\/TCP.n.2019.68","article-title":"Highlights from the 2019 AGS Beers Criteria\u00ae Updates","volume":"35","author":"Charles","year":"2020","journal-title":"Sr. Care Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.11613\/BM.2013.018","article-title":"The chi-square test of independence","volume":"23","author":"McHugh","year":"2013","journal-title":"Biochem. Med."},{"key":"ref_37","unstructured":"(2021, June 28). Laerd Statistics. Available online: https:\/\/statistics.laerd.com\/spss-tutorials\/mann-whitney-u-test-using-spss-statistics.php."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"511S","DOI":"10.1093\/advances\/nmy023","article-title":"Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications","volume":"9","author":"Miller","year":"2018","journal-title":"Adv. Nutr."},{"key":"ref_39","unstructured":"(2012). LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, National Institute of Diabetes and Digestive and Kidney Diseases."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"143","DOI":"10.14336\/AD.2017.0306","article-title":"A Comprehensive Review of Non-Steroidal Anti-Inflammatory Drug Use in the Elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejim.2015.03.008","article-title":"Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies","volume":"26","author":"Ungprasert","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"280.e1","DOI":"10.1016\/j.amjmed.2006.02.015","article-title":"NSAID use and progression of chronic kidney disease","volume":"120","author":"Gooch","year":"2007","journal-title":"Am. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Kate, R.J., Perez, R.M., Mazumdar, D., Pasupathy, K.S., and Nilakantan, V. (2016). Prediction and detection models for acute kidney injury in hospitalized older adults. BMC Med. Inform. Decis. Mak., 16.","DOI":"10.1186\/s12911-016-0277-4"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11255-016-1431-8","article-title":"Clinical outcomes of acute kidney injury developing outside the hospital in elderly","volume":"49","author":"Turgutalp","year":"2017","journal-title":"Int. Urol. Nephrol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1080\/0886022X.2016.1216714","article-title":"Community-acquired hyperkalemia in elderly patients: Risk factors and clinical outcomes","volume":"38","author":"Turgutalp","year":"2016","journal-title":"Ren. Fail."},{"key":"ref_46","first-page":"222","article-title":"Drug-Induced Hyponatremia: NSAIDs, a Neglected Cause that Should Be Considered","volume":"8","author":"Damanti","year":"2019","journal-title":"J. Frailty Aging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.arr.2012.04.006","article-title":"Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: A systematic review","volume":"12","author":"Mannesse","year":"2013","journal-title":"Ageing Res. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.maturitas.2013.08.010","article-title":"Characteristics, prevalence, risk factors, and underlying mechanism of hyponatremia in elderly patients treated with antidepressants: A cross-sectional study","volume":"76","author":"Mannesse","year":"2013","journal-title":"Maturitas"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"628","DOI":"10.31925\/farmacia.2020.4.7","article-title":"The prevalence of inappropriate use of NSAIDs by cardiovascular patients for musculoskeletal disorders","volume":"68","author":"Suciu","year":"2020","journal-title":"Farmacia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nefro.2019.06.009","article-title":"Melatonin ameliorates the drug induced nephrotoxicity: Molecular insights","volume":"40","author":"Raza","year":"2020","journal-title":"Nefrologia"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"912","DOI":"10.31925\/farmacia.2020.5.19","article-title":"Real life anticoagulant treatment for stroke prevention in patients with nonvalvular atrial fibrillation","volume":"68","author":"Sabau","year":"2020","journal-title":"Farmacia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/ajg.2016.156","article-title":"Long-Term PPI Use: Balancing Potential Harms and Documented Benefits","volume":"111","author":"Laine","year":"2016","journal-title":"Am. J. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","article-title":"The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice from the American Gastroenterological Association","volume":"152","author":"Freedberg","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s11255-018-1908-8","article-title":"The use of anti-ulcer agents and the risk of chronic kidney disease: A meta-analysis","volume":"50","author":"Sun","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fneur.2018.01142","article-title":"PPI Long Term Use: Risk of Neurological Adverse Events?","volume":"9","author":"Novotny","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1136\/ejhpharm-2018-001697","article-title":"Prescription of proton pump inhibitors in older adults with complex polytherapy","volume":"27","author":"Cena","year":"2020","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_57","unstructured":"Journey, J.D., and Bentley, T.P. (2021, January 20). Theophylline Toxicity, StatPearls, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532962\/."},{"key":"ref_58","first-page":"52","article-title":"Theophylline interactions","volume":"293","author":"Khan","year":"2014","journal-title":"Respir. Med. J."},{"key":"ref_59","unstructured":"Eurostat (2021, February 15). Cardiovascular Disease Statistics. Available online: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php\/Cardiovascular_diseases_statistics#Self-reporting_of_hypertensive_diseases."},{"key":"ref_60","first-page":"535","article-title":"Theophyllin\u2013R\u00fcckblick, Standortbestimmung und Ausblick [Theophylline--past present and future]","volume":"48","author":"Wettengel","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s40266-018-0569-8","article-title":"Insomnia in Elderly Patients: Recommendations for Pharmacological Management","volume":"35","author":"Abad","year":"2018","journal-title":"Drugs Aging"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pandi-Perumal, S.R., and Monti, J.M. (2006). Overview of currently available benzodiazepine and nonbenzodiazepine hypnotics. Clinical Pharmacology of Sleep, Birkh\u00e4user. Available online: https:\/\/doi.org\/10.1007\/3-7643-7440-3_14.","DOI":"10.1007\/3-7643-7440-3_14"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC Scientific Document Group. 2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s00228-019-02722-0","article-title":"2015 Beers Criteria and STOPP v2 for detecting potentially inappropriate medication in community-dwelling older people: Prevalence, profile, and risk factors","volume":"75","year":"2019","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1590\/1806-9282.66.7.918","article-title":"Beers AGS 2019 criteria in very old hospitalized patients","volume":"66","author":"Gorzoni","year":"2020","journal-title":"Rev. Assoc. Med. Bras."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Kim, G.J., Lee, K.H., and Kim, J.H. (2018). South Korean geriatrics on Beers Criteria medications at risk of adverse drug events. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0191376"},{"key":"ref_67","first-page":"561","article-title":"Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania","volume":"10","author":"Ancusa","year":"2015","journal-title":"Clin. Interv. Aging"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Simionescu, M., Bilan, S., Gavurova, B., and Bordea, E.N. (2019). Health Policies in Romania to Reduce the Mortality Caused by Cardiovascular Diseases. Int. J. Environ. Res. Public Health, 16.","DOI":"10.3390\/ijerph16173080"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2147\/PPA.S162965","article-title":"Treatment adherence among adult hypertensive patients: A cross-sectional retrospective study in primary care in Romania","volume":"12","author":"Tilea","year":"2018","journal-title":"Patient Prefer. Adherence"},{"key":"ref_70","unstructured":"Eurostat 2017 (2021, January 20). Health Expenditure Statistics. Available online: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=Healthcare_expenditure_statistics#Healthcare_expenditure_by_function."},{"key":"ref_71","unstructured":"OECD (2019). Health at a Glance 2019: OECD Indicators, OECD Publishing."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/eurheartj\/ehv770","article-title":"Mobile technology and the digitization of healthcare","volume":"37","author":"Bhavnani","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/papt.12222","article-title":"The digital revolution and its impact on mental health care","volume":"92","author":"Bucci","year":"2019","journal-title":"Psychol. Psychother."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Agbo, C.C., Mahmoud, Q.H., and Eklund, J.M. (2019). Blockchain Technology in Healthcare: A Systematic Review. Healthcare, 7.","DOI":"10.3390\/healthcare7020056"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"104246","DOI":"10.1016\/j.ijmedinf.2020.104246","article-title":"The benefits and threats of blockchain technology in healthcare: A scoping review","volume":"142","author":"Hassan","year":"2020","journal-title":"Int. J. Med. Inform."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1037\/amp0000298","article-title":"Teamwork in healthcare: Key discoveries enabling safer, high-quality care","volume":"73","author":"Rosen","year":"2018","journal-title":"Am. Psychol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/gerona\/glv013","article-title":"Polypharmacy among Adults Aged 65 Years and Older in the United States: 1988-2010","volume":"70","author":"Charlesworth","year":"2015","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_78","unstructured":"United Nations (2021, February 15). Aging. Available online: https:\/\/www.un.org\/en\/sections\/issues-depth\/ageing\/."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/13\/7043\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:24:36Z","timestamp":1760163876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/13\/7043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":78,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["ijerph18137043"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18137043","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}